Skip to main content
SpringerLink
Log in

Origins and Treatment of Right Ventricular Dysfunction After Heart Transplantation

  • Chapter
Congenital Diseases in the Right Heart

  • 1077 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Addonizio LJ, Gersony WM, Robbins RC, Drusin RE, Smith CR, Reison DS, Reemtsma K, Rose EA. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation. 1987;76(Suppl V):V–52.

    Google Scholar 

  2. Addonizio LJ, Gersony WM, Rose EA. Cardiac transplantation in children with increased pulmonary vascular resistance. Am Heart J. 1986;112:647. [Abstract]

    Google Scholar 

  3. Armitage JM, Hardesty RL, Griffith BP. Prostaglandin E1: an effective treatment of right heart failure after orthotopic heart transplantation. J Heart Transplant. 1987;6:348–51.

    PubMed  CAS  Google Scholar 

  4. Bailey LL, Gundry SR, Razzouk AJ, Wang N, Sciolaro CM, Chiavarelli M. Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. J Thorac Cardiovasc Surg. 1993;105:805–15.

    PubMed  CAS  Google Scholar 

  5. Bando K, Konishi H, Komatsu K, Fricker FJ, del Nido PJ, Francalancia NA, Hardesty RL, Griffith BP, Armitage JM. Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation. 1993;88[part2]:218–223.

    Google Scholar 

  6. Bauer J, Dapper F, Demirakca S, Knothe C, Thul J, Hagel KJ. Perioperative management of pulmonary hypertension after heart transplantation in childhood. J Heart Lung Transplant. 1997;16:1238–47.

    PubMed  CAS  Google Scholar 

  7. Bhatia SJ, Kirshenbaum JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, Young PJ, Mudge GH, Sutton MG. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 1987;76:819–826.

    PubMed  CAS  Google Scholar 

  8. Bittner H, Chen E, Milano CA, Kendall SWH, Jennings RB, Sabiston DC, Van Trigt P. Myocardial β-adrenergic receptor function and high-energy phosphates in brain death-related cardiac dysfunction. Circulation. 1995;92:472–478.

    CAS  Google Scholar 

  9. Bourge RC, Naftel DC, Costanzo-Nordin MR. Kirklin JK, Young JB, Kubo SH, Olivari MT, Kasper EK. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. J Heart Lung Transplant. 1993;12:549–62.

    PubMed  CAS  Google Scholar 

  10. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thoracic Cardiovasc Surg. 1991;101:432–45.

    CAS  Google Scholar 

  11. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society of Heart and Lung Transplantation: eighth official pediatric report – 2005. J Heart Lung Transplant. 2005;24:968–82.

    Article  PubMed  Google Scholar 

  12. Chen EP, Bittner HB, Davis RD, Van Trigt P. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of pulmonary hypertension. J Heart Lung Transplant. 1998;17:669–678.

    PubMed  CAS  Google Scholar 

  13. Chen JM, Levin HR, Michler RE, Prusmack CJ, Rose EA, Aaronson KD. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114(4):627–34.

    Article  PubMed  CAS  Google Scholar 

  14. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48–54.

    Article  PubMed  CAS  Google Scholar 

  15. Dujardin KS, McCully RB, Wijdicks, EFM, Tazelaar HD, Seward JB, McGregor CGA, Olson LJ. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. JHLT 2001;20:350–7.

    CAS  Google Scholar 

  16. Erikson KW, Costanzo-Nordin MR, O’Sullivan J, Johnson MR, Zucker MJ, Pifarre R, Lawless CE, Robinson JA, Scanlon PJ. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 1990;526–37.

    Google Scholar 

  17. Gajarski RJ, Towbin JA, Bricker JT, Radovancevic B, Frazier OH, Price JK, Schowengerdt KO, Denfield SW. Intermediate follow up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol. 1994;23:1682–7.

    PubMed  CAS  Google Scholar 

  18. Galinanes M, Hearse DJ. Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res. 1992;71:1213–1219.

    PubMed  CAS  Google Scholar 

  19. Gallardo A, Anguita M, Franco M, et al. The echocardiographic findings in patients with brain death. The implications for their selection as heart transplant donors. Rev Esp Cardiol. 1994;47:604–8.

    PubMed  CAS  Google Scholar 

  20. Gilbert EM, Kreuger SK, Murray JL, et al. Echocardiographic evaluation of potential cardiac transplant donors. J Thorac Cardiovasc Surg. 1988;95:1003–7.

    PubMed  CAS  Google Scholar 

  21. Griepp RB, Stinson EB, Dong Jr E, Clark DA, Shumway NE. Determinants of operative risk in human heart transplantation. Am J Surg. 1971;122:192–197.

    Article  PubMed  CAS  Google Scholar 

  22. Guyton AC, Lindsey AW, Gilluly JJ. The limits of right ventricular compensation following acute increase in pulmonary circulatory resistance. Circ Res. 1954;11:326–332.

    Google Scholar 

  23. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Report – 2000. J Heart Lung Transplant. 2000;19:909.

    Article  PubMed  CAS  Google Scholar 

  24. Kieler-Jensen N, Lundin S, Ricksten S-E. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant. 1995;14:436–43.

    PubMed  CAS  Google Scholar 

  25. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7:331–6.

    PubMed  CAS  Google Scholar 

  26. Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol. 1988;II:917–24.

    Google Scholar 

  27. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: Neurogenic stunned myocardium. JACC 1994;24:636–40.

    PubMed  CAS  Google Scholar 

  28. Kono T, Nishina T, Morita H, Hirota Y, Kawamura K, Fujiwara A. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. Am J Cardiol. 1999;84:578–82.

    Article  PubMed  CAS  Google Scholar 

  29. Lee FA. Hemodynamics of the right ventricle in normal and disease states. Cardiol Clin. 1992;10:59–67.

    PubMed  CAS  Google Scholar 

  30. Li J, Konstantinov IE, Shimizu M, Cai S, Redington AN. Systemic and myocardial oxygen transport responses to brain death in pigs. 2006. In press.

    Google Scholar 

  31. Mertes PM, El Abassi K, Jaboin Y, Burtin P, Pinelli G, Carteaux JP, Burlet C, Boulange M, Villemot JP. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation. 1994;58:414–418.

    Article  PubMed  CAS  Google Scholar 

  32. Mertes PM, Burtin P, Carteaux JP, Jaboin Y, Dopff C, Pinelli G, Villemot JP, Burlet C, Boulange M. Brain death and myocardial injury: role of cardiac sympathetic innervation evaluated by in vivo interstitial microdialysis. Transp Proc. 1994;26:231–232.

    CAS  Google Scholar 

  33. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy S, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993;126:896–902.

    Article  PubMed  CAS  Google Scholar 

  34. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transp Proc. 1997;29:3770–3772.

    Article  CAS  Google Scholar 

  35. Pascual JMS, Fiorelli AI, Bellotti GM, Stolf NAG, Jatene AD. Prostacyclin in the management of pulmonary hypertension after heart transplantation. J Heart Transplant. 1990; 644–51.

    Google Scholar 

  36. Powner DJ, Hendrich A, Nyhuis A, Strate R. Changes in serum catecholamine levels in patients who are brain dead. J Heart Lung Transplant. 1992;11:1046–53.

    PubMed  CAS  Google Scholar 

  37. Pratschke J, Wilhelm MJ, Kusaka M, Hancock WW, Tilney NL. Activation of proinflammatory genes in somatic organs as a consequence of brain death. Transp Proc. 1999;31:1003–1005.

    Article  CAS  Google Scholar 

  38. Radovancevic B, Nakatani T, Frazier OH, Moncrief C, Vega J, Haupt H, Duncan JM. Mechanical circulatory support for perioperative donor heart failure. ASAIO Transactions. 1989;35:539–541.

    Article  PubMed  CAS  Google Scholar 

  39. Ryan JB, Hicks M, Cropper JR, Garlick SR, Kesteven SH, Wilson MK, Feneley MP, Macdonald PS. Functional Evidence of reversible ischemic injury immediately after the sympathetic storm associated with experimental brain death. JHLT. 2003;22: 922–928.

    Google Scholar 

  40. Shemie SD, Ross H, Pagliarello J, Baker AJ, Greig PD, Brand T, Cockfield S, Keshavjee S, Nickerson P, Rao V, Guest C, Young K, Doig C, on behalf of the Pediatric Recommendations Group: Organ management in Canada: recommendations of the Forum on Medical Management to Optimize Donor Organ Potential. Can Med Assoc J. 2006;174(6):S13–S30.

    Article  Google Scholar 

  41. Shivalkar B, Van Loon J, Wieland W, Tjandra–Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87:230–9.

    PubMed  CAS  Google Scholar 

  42. Smith WJ, Murphy MP, Appleyard RF, Rizzo RJ, Aklog L, Laurence RG, Cohn LH. Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism. J Thorac Cardiovasc Surg. 1994;107:800–6.

    PubMed  CAS  Google Scholar 

  43. Stobiersak-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001;38:923–931.

    Article  Google Scholar 

  44. Tenderich G, Koerner MM, Stuettgen B, Mirow N, Arusoglu L, Morshuis M, Bairaktaris A, Minami K, Koerger R. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation. J Cardiovasc Surg. 2000;41: 215–19.

    CAS  Google Scholar 

  45. Tenderich G, Koerner MM, Stuettgen B, Hornik L, Mirow N, Morshuis M, Mannebach H, Minami K, Koerfer R. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mmHg or >5 Wood) predict early and long-term results after orthotopic heart transplantation? Transp Proc. 1998;30:1130–1131.

    Article  CAS  Google Scholar 

  46. Tenderich G, Koerner MM, Stuettgen B, Minami K, El-Banayosy A, Arusoglu L, Mirow N, Wlost S, Gromzik H, Kleesiek K, Meyer H, Koerfer R. Mechanical circulatory support after orthotopic heart transplantation. Int J Artif Organs. 1998;21:414–416.

    PubMed  CAS  Google Scholar 

  47. Vincent JL, Carlier E, Pinsky MR, Goldstein J, Naeije R, Lejeune P, Brimioulle S, Leclerc JL, Kahn RJ, Primo G. Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg. 1992;103: 33–9.

    PubMed  CAS  Google Scholar 

  48. White M, Wiechmann RJ, Roden RL, Hagan MB, Wollmering MM, Port JD, Hammond E, Abraham WT, Wolfel EE, Lindenfeld J, Fullerton D, Bristow MR. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation. 1995;92:2183–2189.

    PubMed  CAS  Google Scholar 

  49. Williams TJ, Salamonsen RF, Snell G, Kaye D, Esmore DS. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant. 1995;14:419–23.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada

    Anne I. Dipchand MD

Authors
  1. Anne I. Dipchand MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, Canada

    Andrew N. Redington  & Glen S. Van Arsdell  & 

  2. Cardiac Unit, Institute of Child Health, University College London, London, UK

    Robert H. Anderson

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Dipchand, A.I. (2009). Origins and Treatment of Right Ventricular Dysfunction After Heart Transplantation. In: Redington, A.N., Van Arsdell, G.S., Anderson, R.H. (eds) Congenital Diseases in the Right Heart. Springer, London. https://doi.org/10.1007/978-1-84800-378-1_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-378-1_24

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-377-4

  • Online ISBN: 978-1-84800-378-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation